MTOR and breast cancer: The activated mTOR protein promotes substrate phosphorylation and gene transcription, activates the non‐ligand‐dependent transcription activation function 1 (AF‐1), induces phosphorylation of ERα and promotes proliferation and invasion of breast cancer cells, causing endocrine therapy resistance.